NanoLogix, Inc. (NNLX) Stock

About NanoLogix, Inc.

NanoLogix, Inc., a biotechnology firm, specializes in developing and providing rapid diagnostic and live cell test kits. These kits are designed to accurately detect viable bacteria and a wide array of other microorganisms. Among its key offerings are the BioNanoPore kit, which utilizes a unique water-permeable membrane capable of interacting with organic, inorganic molecules, and proteins. Another significant product is the FlatPack Petri Plate, essential for the isolation and cultivation of diverse microorganisms, including both fastidious and non-fastidious types, as well as those requiring or not requiring oxygen for growth (aerobic and anaerobic respectively). The company's solutions are applied across a broad spectrum of sectors, including medical diagnostics, national defense, homeland security initiatives, pharmaceutical research and manufacturing, industrial processes, veterinary science, and environmental monitoring. NanoLogix serves an established clientele comprising prominent medical and scientific organizations. This includes laboratories, healthcare institutions, academic universities, various businesses, and specialized research establishments. Headquartered in Hubbard, Ohio, NanoLogix, Inc. operates from this location.

NanoLogix, Inc. (NNLX) stock trades at $0.00 with a market capitalization of $9569. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of 0.01, price-to-sales of 0.27. Over the past 52 weeks the stock has ranged between $0.00 and $0.04, and currently trades 100.0% below its 52-week high.

On profitability, NanoLogix, Inc. generates a return on equity (ROE) of -100.00%, return on capital employed of -212.56%, an operating margin of -424549.20%, a net profit margin of 0.00%.

Official website: nanologix.com